Eravacycline susceptibility was impacted by genetic mutation of 30S ribosome subunits, and branched-chain amino acid transport system II carrier protein, Na/Pi cotransporter family protein in Staphylococcus aureus
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Eravacycline susceptibility was impacted by genetic mutation of 30S ribosome subunits, and branched-chain amino acid transport system II carrier protein, Na/Pi cotransporter family protein in Staphylococcus aureus
Authors
Keywords
-
Journal
BMC MICROBIOLOGY
Volume 20, Issue 1, Pages -
Publisher
Springer Science and Business Media LLC
Online
2020-07-01
DOI
10.1186/s12866-020-01869-6
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- In vitro Activity and Heteroresistance of Omadacycline Against Clinical Staphylococcus aureus Isolates From China Reveal the Impact of Omadacycline Susceptibility by Branched-Chain Amino Acid Transport System II Carrier Protein, Na/Pi Cotransporter Family Protein, and Fibronectin-Binding Protein
- (2019) Bing Bai et al. Frontiers in Microbiology
- Surveillance of tigecycline activity tested against clinical isolates from a global (North America, Europe, Latin America and Asia-Pacific) collection (2016)
- (2018) Michael A. Pfaller et al. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
- Resistance in In Vitro Selected Tigecycline-Resistant Methicillin-Resistant Staphylococcus aureus Sequence Type 5 Is Driven by Mutations in mepR and mepA Genes
- (2018) Andrei Nicoli Gebieluca Dabul et al. Microbial Drug Resistance
- Molecular analysis of low-level tetracycline resistance in clinical isolates of Helicobacter pylori among dyspeptic patients in South West Nigeria
- (2018) Abiodun T. Seriki et al. Journal of Global Antimicrobial Resistance
- Eravacycline activity against clinical S. aureus isolates from China: in vitro activity, MLST profiles and heteroresistance
- (2018) Fan Zhang et al. BMC MICROBIOLOGY
- First description of rpsJ and mepA mutations associated with tigecycline resistance in Staphylococcus aureus isolated from a cystic fibrosis patient during antibiotic therapy
- (2017) M.S. Haim et al. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
- Trends in Community Versus Health Care-Acquired Methicillin-Resistant Staphylococcus aureus Infections
- (2017) David P. Calfee Current Infectious Disease Reports
- Future trends in the treatment of methicillin-resistant Staphylococcus aureus (MRSA) infection: An in-depth review of newer antibiotics active against an enduring pathogen
- (2017) A.M. Bal et al. Journal of Global Antimicrobial Resistance
- Genomic Characterization of Colistin Heteroresistance in Klebsiella pneumoniae during a Nosocomial Outbreak
- (2016) Teysir Halaby et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Review of Eravacycline, a Novel Fluorocycline Antibacterial Agent
- (2016) George G. Zhanel et al. DRUGS
- Tetracycline Antibiotics and Resistance
- (2016) Trudy H. Grossman Cold Spring Harbor Perspectives in Medicine
- Potential of Tetracycline Resistance Proteins To Evolve Tigecycline Resistance
- (2015) Marius Linkevicius et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Deletions in a ribosomal protein-coding gene are associated with tigecycline resistance in Enterococcus faecium
- (2015) Marc Niebel et al. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
- Tigecycline resistance in clinical isolates ofEnterococcus faeciumis mediated by an upregulation of plasmid-encoded tetracycline determinantstet(L) andtet(M)
- (2015) S. Fiedler et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Genomic Analysis of Reduced Susceptibility to Tigecycline in Enterococcus faecium
- (2014) Vincent Cattoir et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Tetracycline antibiotics and resistance mechanisms
- (2014) Fabian Nguyen et al. BIOLOGICAL CHEMISTRY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started